APA (7th ed.) Citation

Pitiyarachchi, O., Ansell, P. J., Coleman, R. L., Dinh, M. H., Holman, L., Leath III, C. A., . . . Reid, T. (2024). Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over. Gynecologic Oncology, 187, 221. https://doi.org/10.1016/j.ygyno.2024.05.021

Chicago Style (17th ed.) Citation

Pitiyarachchi, Omali, et al. "Homologous Recombination Deficiency Should Be Tested for in Patients with Advanced Stage High-grade Serous Ovarian Cancer Aged 70 years and over." Gynecologic Oncology 187 (2024): 221. https://doi.org/10.1016/j.ygyno.2024.05.021.

MLA (9th ed.) Citation

Pitiyarachchi, Omali, et al. "Homologous Recombination Deficiency Should Be Tested for in Patients with Advanced Stage High-grade Serous Ovarian Cancer Aged 70 years and over." Gynecologic Oncology, vol. 187, 2024, p. 221, https://doi.org/10.1016/j.ygyno.2024.05.021.